Malignant Mesothelioma of the Pleura

Mayo Clinic Proceedings

Volumn 63, Issue 12, 1988, Pages 1234-1244

  PISANI, RICHARD J ^a   COLBY, THOMAS V ^b   WILLIAMS, DAVID E ^a  

^a Division of Thoracic Diseases and Internal Medicine ^*

^b Division of Pathology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; DOXORUBICIN; MITOMYCIN;

HUMAN; MALIGNANT MESOTHELIOMA; PLEURA EFFUSION; PLEURA TUMOR; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

EID: 0024273966     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)65411-1     Document Type: Review

References (78)

1. Recent trends in mesothelioma incidence in the United States
2. Malignant mesothelioma with occupational and environmental asbestos exposure in an Illinois community hospital
3. Zur Geographie des Pleuracarcinoms
4. Diffuse pleural mesothelioma and asbestos exposure in the north western Cape Province
5. The clinical aspects of mesothelioma
6. Relation between exposure to asbestos and mesothelioma
7. Diffuse malignant pleural mesothelioma and asbestos exposure
8. Das tuberkelahnliche Lymphadenom
9. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature
10. Localized mesothelioma of the pleura: benign and malignant variants
11. Localized primary tumors of the pleura: an analysis of 40 cases
12. Clinical presentation and natural history of benign and malignant mesothelioma
13. Malignant mesothelioma in childhood: report of 13 cases
14. Non-occupational exposure to asbestos and malignant mesothelioma in females
15. Epidemiology of primary malignant mesothelial tumors in Canada
16. Malignant pleural mesothelioma: report of 19 cases
17. The hygiene standard for chrysotile asbestos
18. Latency of asbestos disease among insulation workers in the United States and Canada
19. Pleural carcinogenic potency of mineral fibers (asbestos, attapulgite) and their cytotoxicity on cultured cells
20. Mesotheliomata in rats after inoculation with asbestos and other materials
21. Malignant mesothelioma 1982: review of 4710 published cases
22. Long-term mortality experience of chrysotile miners and millers in Thetford Mines, Quebec
23. Chrysotile, tremolite, and malignant mesothelioma in man
24. Association of metsovo lung and pleural mesothelioma with exposure to tremolite-containing whitewash
25. Asbestos disease in Finland
26. Mesothelioma following exposure to asbestos: a review of 72 cases
27. Diffuse malignant mesothelioma
28. Malignant mesothelioma of the pleura in Barrow-in-Furness
29. Diffuse malignant pleural mesothelioma in Glasgow
30. Malignant mesothelioma—clinical and epidemiological features: a report of 80 cases
31. Diffuse malignant mesothelioma of the pleura: a review of 37 cases
32. Malignant mesothelioma: the University of Minnesota experience
33. Screening of autopsy populations for previous occupational exposure to asbestos
34. Malignant peritoneal mesothelioma following radiotherapy for seminoma of the testis
35. A primary mesothelioma involving the rectovaginal septum and associated with beryllium
36. Mesotheliomas of peritoneum, epicardium, and pericardium induced by strain MC29 avian leukosis virus
37. Mesothelioma associated with the shipbuilding industry in coastal Virginia
38. Multimodality therapy for malignant mesothelioma based on a study of natural history
39. Diffuse malignant mesothelioma of pleura: diagnosis and survival in 92 cases
40. Radiological features of diffuse mesothelioma
41. The radiology of thoracic malignant mesothelioma
42. Follow-up study of 100 malignant pleural mesotheliomas
43. Gallium-67 scanning in the evaluation of mesothelioma
44. CT of malignant pleural mesothelioma
45. Pleural mesotheliomas—an analysis of 18 cases and review of the literature
46. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases
47. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy
48. Mortality experience of insulation workers in the United States and Canada, 1943–1976
49. Solitary (localized) fibrous mesothelioma: evidence against mesothelial cell origin
50. Pathology of human mesothelioma: etiologic and diagnostic considerations
51. Pleural biopsy in the diagnosis of malignant mesothelioma
52. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies
53. Reactive and neoplastic serosal tissue: a light-microscopic, ultrastructural, and immunocytochemical study
54. Immunohistochemical staining in malignant mesotheliomas
55. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas
56. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium
57. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance
58. Distinction of mesothelioma from adenocarcinoma: an immunohistochemical approach
59. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen; an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas
60. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma: a bi-institutional study of 47 cases
61. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3)
62. New marker for mesothelioma: an immunoperoxidase study
63. Contribution of electron microscopy to the diagnosis of pleural mesothelioma
64. Malignant mesotheliomas: improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44–3A6 and 624A12
65. Monoclonal antibodies to human malignant mesothelioma
66. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura
67. Prevalence and incidence of benign asbestos pleural effusion in the working population
68. Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study
69. Surgical treatment of pleural mesothelioma
70. Randomized comparison of cyclophosphamide, imidazole carboxamide, and Adriamycin versus cyclophosphamide and Adriamycin in patients with advanced stage malignant mesothelioma: a sarcoma intergroup study
71. The role of surgery in diffuse malignant mesothelioma of the pleura
72. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients
73. The value of Adriamycin in the treatment of diffuse malignant pleural mesothelioma
74. Chemotherapy for malignant mesothelioma: CAMEO
75. Pleural mesothelioma
76. Surgical management of malignant mesothelioma